Verastem | VSTM - Current Assets


Verastem reported $202.9M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Curis USD 16.61M 9.7M Mar/2026
Cytokinetics USD 1.21B 369.02M Jun/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
Incyte USD 6.03B 542.31M Jun/2026
Laboratory Of America USD 3.81B 743.9M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
TG Therapeutics USD 1.15B 58.72M Jun/2026
Verastem USD 202.9M 20.51M Mar/2026